BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Seattle - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinseattle.com
X-WR-CALDESC:Events for Science in Seattle
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230208T120000
DTEND;TZID=America/Vancouver:20230208T130000
DTSTAMP:20260405T163143
CREATED:20230130T173927Z
LAST-MODIFIED:20230130T173927Z
UID:21231-1675857600-1675861200@scienceinseattle.com
SUMMARY:Biostatistics Seminar Series Featuring Dr. Noorie Hyun
DESCRIPTION:n this big data era\, we can easily observe substantial amounts of clinical data in large observational studies or electronic health records (EHR). Data accuracy can vary according to measurement methods. For example\, self-reported medical history can include bias\, such as recall bias or response bias. In contrast\, gold standard diagnostic tests are less likely to be biased but may not be available on all individuals in a large prospective study due to cost or participant burden. We are motivated to study what benefit we can gain by augmenting analyses of the gold standard disease outcome with error-prone self-reported disease diagnoses in regression for time-to-disease onset. The proposed model addresses left-truncation and interval-censoring in time-to-disease onset outcomes while correcting errors in self-reported disease diagnosis in a joint likelihood for the gold standard and error-prone outcomes. The proposed model is applied to the Hispanic Community Health Study/ Study of Latino data to quantify risk factors associated with diabetes onset.
URL:https://scienceinseattle.com/event/biostatistics-seminar-series-featuring-dr-noorie-hyun/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230208T120000
DTEND;TZID=America/Vancouver:20230208T130000
DTSTAMP:20260405T163143
CREATED:20230130T173927Z
LAST-MODIFIED:20230130T173927Z
UID:26941-1675857600-1675861200@scienceinseattle.com
SUMMARY:Biostatistics Seminar Series Featuring Dr. Noorie Hyun
DESCRIPTION:n this big data era\, we can easily observe substantial amounts of clinical data in large observational studies or electronic health records (EHR). Data accuracy can vary according to measurement methods. For example\, self-reported medical history can include bias\, such as recall bias or response bias. In contrast\, gold standard diagnostic tests are less likely to be biased but may not be available on all individuals in a large prospective study due to cost or participant burden. We are motivated to study what benefit we can gain by augmenting analyses of the gold standard disease outcome with error-prone self-reported disease diagnoses in regression for time-to-disease onset. The proposed model addresses left-truncation and interval-censoring in time-to-disease onset outcomes while correcting errors in self-reported disease diagnosis in a joint likelihood for the gold standard and error-prone outcomes. The proposed model is applied to the Hispanic Community Health Study/ Study of Latino data to quantify risk factors associated with diabetes onset.
URL:https://scienceinseattle.com/event/biostatistics-seminar-series-featuring-dr-noorie-hyun-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230209T173000
DTEND;TZID=America/Vancouver:20230209T193000
DTSTAMP:20260405T163143
CREATED:20230112T155236Z
LAST-MODIFIED:20230112T155236Z
UID:20978-1675963800-1675971000@scienceinseattle.com
SUMMARY:Innovators Network Lab Crawl
DESCRIPTION:Big data\, biopsies\, bugs\, oh my! Join us at the Lake Union Steam Plant on Thursday\, February 9\, for a lab crawl. Get a behind-the-scenes look at our immunotherapy and data science work\, meet Fred Hutch researchers\, and see our leading-edge science in action. \nPlease feel free to invite other young professionals who share your interest in preventing and eliminating cancer and infectious disease to this complimentary event. RSVP by February 6. \nDon’t forget to wear your comfy shoes. Attendees will walk the halls of the Lake Union Steam Plant\, enjoy light snacks and refreshments\, and go inside the research labs to connect directly with Fred Hutch scientists. \nQuestions?\n206.667.2840 | events@fredhutch.org \nFred Hutch is committed to providing a safe experience for our participants\, patients\, volunteers\, vendors\, staff\, and the communities that welcome us. The guidance for COVID-19 safety is ever changing\, and we will continue to monitor\, and adhere to\, the latest guidance for masks\, social distancing\, and other protocols as outlined by the CDC\, Washington State Department of Health\, and local authorities/agencies.
URL:https://scienceinseattle.com/event/innovators-network-lab-crawl/
LOCATION:Lake Union Steam Plant
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2023/01/Registration-Innovators_Network-Lab_Crawl.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230209T173000
DTEND;TZID=America/Vancouver:20230209T193000
DTSTAMP:20260405T163143
CREATED:20230112T155236Z
LAST-MODIFIED:20230112T155236Z
UID:26938-1675963800-1675971000@scienceinseattle.com
SUMMARY:Innovators Network Lab Crawl
DESCRIPTION:Big data\, biopsies\, bugs\, oh my! Join us at the Lake Union Steam Plant on Thursday\, February 9\, for a lab crawl. Get a behind-the-scenes look at our immunotherapy and data science work\, meet Fred Hutch researchers\, and see our leading-edge science in action. \nPlease feel free to invite other young professionals who share your interest in preventing and eliminating cancer and infectious disease to this complimentary event. RSVP by February 6. \nDon’t forget to wear your comfy shoes. Attendees will walk the halls of the Lake Union Steam Plant\, enjoy light snacks and refreshments\, and go inside the research labs to connect directly with Fred Hutch scientists. \nQuestions?\n206.667.2840 | events@fredhutch.org \nFred Hutch is committed to providing a safe experience for our participants\, patients\, volunteers\, vendors\, staff\, and the communities that welcome us. The guidance for COVID-19 safety is ever changing\, and we will continue to monitor\, and adhere to\, the latest guidance for masks\, social distancing\, and other protocols as outlined by the CDC\, Washington State Department of Health\, and local authorities/agencies.
URL:https://scienceinseattle.com/event/innovators-network-lab-crawl-2/
LOCATION:Lake Union Steam Plant
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2023/01/Registration-Innovators_Network-Lab_Crawl.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230211T090000
DTEND;TZID=America/Vancouver:20230211T140000
DTSTAMP:20260405T163143
CREATED:20230130T174129Z
LAST-MODIFIED:20230130T174129Z
UID:26942-1676106000-1676124000@scienceinseattle.com
SUMMARY:SEP School Year Workshop: mRNA Vaccines
DESCRIPTION:Join us for our School Year Workshop on our new mRNA Vaccines lessons that are part of the mRNA Vaccines & COVID-19 Testing lesson sequence. The workshop will be held in person on February 11th (9 am – 2 pm).
URL:https://scienceinseattle.com/event/sep-school-year-workshop-mrna-vaccines-2/
LOCATION:Fred Hutch
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230211T090000
DTEND;TZID=America/Vancouver:20230211T140000
DTSTAMP:20260405T163143
CREATED:20230130T174129Z
LAST-MODIFIED:20230130T174129Z
UID:21235-1676106000-1676124000@scienceinseattle.com
SUMMARY:SEP School Year Workshop: mRNA Vaccines
DESCRIPTION:Join us for our School Year Workshop on our new mRNA Vaccines lessons that are part of the mRNA Vaccines & COVID-19 Testing lesson sequence. The workshop will be held in person on February 11th (9 am – 2 pm).
URL:https://scienceinseattle.com/event/sep-school-year-workshop-mrna-vaccines/
LOCATION:Fred Hutch
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230213T123000
DTEND;TZID=UTC:20230213T133000
DTSTAMP:20260405T163143
CREATED:20230130T175015Z
LAST-MODIFIED:20230130T175015Z
UID:26943-1676291400-1676295000@scienceinseattle.com
SUMMARY:Synthetic Developmental Biology: Cross-species comparison and manipulation of organoids
DESCRIPTION:
URL:https://scienceinseattle.com/event/synthetic-developmental-biology-cross-species-comparison-and-manipulation-of-organoids-2/
LOCATION:Odin Smith Auditorium and Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2023/01/Seminar_Flyer_Ebisuya.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230213T123000
DTEND;TZID=UTC:20230213T133000
DTSTAMP:20260405T163143
CREATED:20230130T175015Z
LAST-MODIFIED:20230130T175015Z
UID:21239-1676291400-1676295000@scienceinseattle.com
SUMMARY:Synthetic Developmental Biology: Cross-species comparison and manipulation of organoids
DESCRIPTION:
URL:https://scienceinseattle.com/event/synthetic-developmental-biology-cross-species-comparison-and-manipulation-of-organoids/
LOCATION:Odin Smith Auditorium and Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2023/01/Seminar_Flyer_Ebisuya.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230213T160000
DTEND;TZID=America/Vancouver:20230214T180000
DTSTAMP:20260405T163143
CREATED:20221117T154801Z
LAST-MODIFIED:20221117T154801Z
UID:20305-1676304000-1676397600@scienceinseattle.com
SUMMARY:Venture Investment & Partnering Foru
DESCRIPTION:Would you like the opportunity to meet with representatives from BMS?\nAre you are researcher or company looking for potential partnership opportunities\, licensing\, or other collaborations with BMS?\nJoin Life Science Washington Institute\, Life Science Washington\, and BMS for a VIP Forum February 13 & 14\, 2023. Download the BMS Factsheet Here. \nThere are two ways to participate in this event: \n\nRSVP to the Plenary Session and Networking Reception (No cost to attend!)\nApply to meet with BMS representatives (deadline December 9)\n\nPlease note BMS requests all attendees be vaccinated. \nFor more information or questions\, contact aylin@lswinstitute.org !
URL:https://scienceinseattle.com/event/venture-investment-partnering-foru/
LOCATION:Life Science Washington\, 1551 Eastlake AVE E\, Seattle\, WA\, 98102\, United States
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230213T160000
DTEND;TZID=UTC:20230214T180000
DTSTAMP:20260405T163143
CREATED:20221129T155049Z
LAST-MODIFIED:20221129T155049Z
UID:25960-1676304000-1676397600@scienceinseattle.com
SUMMARY:VIP Forum with BMS
DESCRIPTION:Venture Investment & Partnering Forums bring investors and strategic partners to Seattle for a showcase of the most promising life science companies and research opportunities in Washington. To read more about VIP Forum opportunities at Life Science Washington Institute\, visit our VIP Forum page. \nWould you like the opportunity to meet with representatives from Bristol Myers Squibb (BMS)? Are you are researcher or company looking for potential partnership opportunities\, licensing\, or other collaborations with BMS? \nJoin Life Science Washington Institute\, Life Science Washington\, and BMS for a VIP Forum on February 13 & 14\, 2023. Download the BMS Factsheet Here. \nThere are two ways to participate in this event: \n• RSVP to the Plenary Session and Networking Reception (No cost to attend!)\n• Apply to meet with BMS representatives (deadline December 9) \nBMS’s Areas of Interest: \nBMS partners with companies with innovative technologies\, products\, and therapies that accelerate growth and advance patient care. BMS is looking to meet with companies and researchers in specific areas of focus to discuss potential collaborations\, partnerships\, investment\, licensing opportunities\, and M&A. BMS is interested in the following areas: \n\nSolid Tumor Oncology\nImmuno-Oncology\nCell Therapy\nManufacturing\, Cell\, and Gene Technologies\n\nPlease note BMS requests all attendees be vaccinated. For more information or questions\, contact aylin@lswinstitute.org.
URL:https://scienceinseattle.com/event/vip-forum-with-bms/
LOCATION:Life Science Washington\, 1551 Eastlake AVE E\, Seattle\, WA\, 98102\, United States
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230213T160000
DTEND;TZID=UTC:20230214T180000
DTSTAMP:20260405T163143
CREATED:20221129T155049Z
LAST-MODIFIED:20221129T155049Z
UID:26925-1676304000-1676397600@scienceinseattle.com
SUMMARY:VIP Forum with BMS
DESCRIPTION:Venture Investment & Partnering Forums bring investors and strategic partners to Seattle for a showcase of the most promising life science companies and research opportunities in Washington. To read more about VIP Forum opportunities at Life Science Washington Institute\, visit our VIP Forum page. \nWould you like the opportunity to meet with representatives from Bristol Myers Squibb (BMS)? Are you are researcher or company looking for potential partnership opportunities\, licensing\, or other collaborations with BMS? \nJoin Life Science Washington Institute\, Life Science Washington\, and BMS for a VIP Forum on February 13 & 14\, 2023. Download the BMS Factsheet Here. \nThere are two ways to participate in this event: \n• RSVP to the Plenary Session and Networking Reception (No cost to attend!)\n• Apply to meet with BMS representatives (deadline December 9) \nBMS’s Areas of Interest: \nBMS partners with companies with innovative technologies\, products\, and therapies that accelerate growth and advance patient care. BMS is looking to meet with companies and researchers in specific areas of focus to discuss potential collaborations\, partnerships\, investment\, licensing opportunities\, and M&A. BMS is interested in the following areas: \n\nSolid Tumor Oncology\nImmuno-Oncology\nCell Therapy\nManufacturing\, Cell\, and Gene Technologies\n\nPlease note BMS requests all attendees be vaccinated. For more information or questions\, contact aylin@lswinstitute.org.
URL:https://scienceinseattle.com/event/vip-forum-with-bms-2/
LOCATION:Life Science Washington\, 1551 Eastlake AVE E\, Seattle\, WA\, 98102\, United States
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230215T120000
DTEND;TZID=America/Vancouver:20230215T133000
DTSTAMP:20260405T163143
CREATED:20230131T175804Z
LAST-MODIFIED:20230131T175804Z
UID:26940-1676462400-1676467800@scienceinseattle.com
SUMMARY:PNRI’s Science Matters Seminar
DESCRIPTION:Complex Structural Variation in a Complete Human Genome with Evan Eichler\, PhD\, Principal Investigator and Professor of Genome Sciences in the Eichler Lab at the University of Washington – Genome Sciences. \nThe complete resolution of genetic variation is critical to understanding the mutational processes underlying both disease and evolution. Dr. Eichler will present his lab’s most recent work sequencing diverse human and non-human apes using both ultra-long Oxford nanopore technology and high-fidelity PacBio long-read sequencing technologies to fully phase and assemble diploid genomes with & without parental data. He will summarize their findings into more complex patterns of structural variation and the new biological insights they reveal.
URL:https://scienceinseattle.com/event/pnris-science-matters-seminar-2-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230215T120000
DTEND;TZID=America/Vancouver:20230215T133000
DTSTAMP:20260405T163143
CREATED:20230131T175804Z
LAST-MODIFIED:20230131T175804Z
UID:21221-1676462400-1676467800@scienceinseattle.com
SUMMARY:PNRI’s Science Matters Seminar
DESCRIPTION:Complex Structural Variation in a Complete Human Genome with Evan Eichler\, PhD\, Principal Investigator and Professor of Genome Sciences in the Eichler Lab at the University of Washington – Genome Sciences. \nThe complete resolution of genetic variation is critical to understanding the mutational processes underlying both disease and evolution. Dr. Eichler will present his lab’s most recent work sequencing diverse human and non-human apes using both ultra-long Oxford nanopore technology and high-fidelity PacBio long-read sequencing technologies to fully phase and assemble diploid genomes with & without parental data. He will summarize their findings into more complex patterns of structural variation and the new biological insights they reveal.
URL:https://scienceinseattle.com/event/pnris-science-matters-seminar-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230215T180000
DTEND;TZID=America/Vancouver:20230215T193000
DTSTAMP:20260405T163143
CREATED:20230213T170154Z
LAST-MODIFIED:20230213T170154Z
UID:21437-1676484000-1676489400@scienceinseattle.com
SUMMARY:Seattle AWIS – Cognitive Decline in Dogs and Humans
DESCRIPTION:Seattle AWIS is excited to invite you to an evening to learn more about cognitive decline in ourselves and our four legged friends. Join speakers Dr. Annette Fitzpatrick and Dr. Valerie Daggett as they share their expertise with us. \nMeet the Speakers \nDr. Annette Fitzpatrick\, PhD; Epidemiologist and Research Professor Emeritus with UW Depts. of Family Medicine and Epidemiology. Annette Fitzpatrick\, PhD\, is an epidemiologist and Research Professor\, Emeritus\, in the Departments of Family Medicine and Epidemiology at the University of Washington (UW) in Seattle. She has devoted her career to research in the field of aging with a focus on risk factors for cardiovascular disease and dementia/cognitive decline (in humans!). She joined the Dog Aging Project (DAP) in 2016 as one of its early investigators and remains active as this incredible study evolves. In addition to DAP\, she has been Principal Investigator of 20 NIH- or CDC-sponsored studies and a co-investigator of an additional 15 more. She is a co-author of over 240 articles in scientific peer-reviewed journals. Dogs have always been a part of her life and now she hangs-out with Greta! \n \nDr. Valerie Daggett\, PhD;  UW Professor in Bioengineering. Dr. Valerie Daggett holds the David and Nancy Auth Endowed Professorship of Bioengineering at the University of Washington. She obtained her B.A. in Chemistry at Reed College\, her PhD in Pharmaceutical Chemistry and the University of California\, San Francisco\, and was a postdoctoral fellow at Stanford University. She has over 250 peer-reviewed publications and is a fellow of the American Institute of Medical and Biological Engineering and The Biophysical Society. She pioneered the approach of simulating protein unfolding and amyloidogenesis\, as well as simulating representatives of all protein folds and developing associated databases and protein design tools. These various studies and approaches came together in the discovery of a new protein structure linked to the toxic species in amyloid diseases\, which is being targeted for diagnostic and therapeutic agents for amyloid diseases\, with a focus on Alzheimer’s Disease. \n \nEvent Details\nEvent starts at 6PM with networking\, drinks and light refreshments. This event is FREE and WELCOMES ALL\, regardless of sex\, gender\, race\, ethnicity\, age\, background or any other characteristic. This event welcomes scientists and non-scientists alike\, and does not require background knowledge. \nFinding the Pelton Auditorium\nThe Pelton Auditorium is located in the Thomas Building. The Thomas building entrance is located off Ward Street. Free parking is available on a first come basis directly outside the building. Please proceed through the main entrance\, past the cafe\, and the Pelton will be located on your right. More details can be found here \nWe will be following the venue guidelines for COVID19 controls. Proof of vaccination is required\, and masking is strongly encouraged.
URL:https://scienceinseattle.com/event/seattle-awis-cognitive-decline-in-dogs-and-humans/
LOCATION:Fred Hutch
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2023/02/cognitive-decline.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230215T180000
DTEND;TZID=America/Vancouver:20230215T193000
DTSTAMP:20260405T163143
CREATED:20230213T170154Z
LAST-MODIFIED:20230213T170154Z
UID:26952-1676484000-1676489400@scienceinseattle.com
SUMMARY:Seattle AWIS – Cognitive Decline in Dogs and Humans
DESCRIPTION:Seattle AWIS is excited to invite you to an evening to learn more about cognitive decline in ourselves and our four legged friends. Join speakers Dr. Annette Fitzpatrick and Dr. Valerie Daggett as they share their expertise with us. \nMeet the Speakers \nDr. Annette Fitzpatrick\, PhD; Epidemiologist and Research Professor Emeritus with UW Depts. of Family Medicine and Epidemiology. Annette Fitzpatrick\, PhD\, is an epidemiologist and Research Professor\, Emeritus\, in the Departments of Family Medicine and Epidemiology at the University of Washington (UW) in Seattle. She has devoted her career to research in the field of aging with a focus on risk factors for cardiovascular disease and dementia/cognitive decline (in humans!). She joined the Dog Aging Project (DAP) in 2016 as one of its early investigators and remains active as this incredible study evolves. In addition to DAP\, she has been Principal Investigator of 20 NIH- or CDC-sponsored studies and a co-investigator of an additional 15 more. She is a co-author of over 240 articles in scientific peer-reviewed journals. Dogs have always been a part of her life and now she hangs-out with Greta! \n \nDr. Valerie Daggett\, PhD;  UW Professor in Bioengineering. Dr. Valerie Daggett holds the David and Nancy Auth Endowed Professorship of Bioengineering at the University of Washington. She obtained her B.A. in Chemistry at Reed College\, her PhD in Pharmaceutical Chemistry and the University of California\, San Francisco\, and was a postdoctoral fellow at Stanford University. She has over 250 peer-reviewed publications and is a fellow of the American Institute of Medical and Biological Engineering and The Biophysical Society. She pioneered the approach of simulating protein unfolding and amyloidogenesis\, as well as simulating representatives of all protein folds and developing associated databases and protein design tools. These various studies and approaches came together in the discovery of a new protein structure linked to the toxic species in amyloid diseases\, which is being targeted for diagnostic and therapeutic agents for amyloid diseases\, with a focus on Alzheimer’s Disease. \n \nEvent Details\nEvent starts at 6PM with networking\, drinks and light refreshments. This event is FREE and WELCOMES ALL\, regardless of sex\, gender\, race\, ethnicity\, age\, background or any other characteristic. This event welcomes scientists and non-scientists alike\, and does not require background knowledge. \nFinding the Pelton Auditorium\nThe Pelton Auditorium is located in the Thomas Building. The Thomas building entrance is located off Ward Street. Free parking is available on a first come basis directly outside the building. Please proceed through the main entrance\, past the cafe\, and the Pelton will be located on your right. More details can be found here \nWe will be following the venue guidelines for COVID19 controls. Proof of vaccination is required\, and masking is strongly encouraged.
URL:https://scienceinseattle.com/event/seattle-awis-cognitive-decline-in-dogs-and-humans-2/
LOCATION:Fred Hutch
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2023/02/cognitive-decline.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230227T080000
DTEND;TZID=America/Vancouver:20230227T090000
DTSTAMP:20260405T163143
CREATED:20230213T165506Z
LAST-MODIFIED:20230213T165506Z
UID:21421-1677484800-1677488400@scienceinseattle.com
SUMMARY:Global Oncology Lecture Series
DESCRIPTION:Kingsley I. Ndoh\, MD\, MPH \nClinical Assistant Professor\, UW Department of Global Health; Affiliate Member\, Fred Hutch Cancer Center; Founder & Chief Strategist\, Hurone AI \nSeminar Title: “Patient-Reported Outcomes: Leveraging medical technology to address the cancer care gap in underrepresented populations” \nJoin us on Zoom \nPlease register in advance for this meeting! \nAfter registering\, you will receive a confirmation email containing information about joining the meeting.
URL:https://scienceinseattle.com/event/global-oncology-lecture-series-10-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230227T080000
DTEND;TZID=America/Vancouver:20230227T090000
DTSTAMP:20260405T163143
CREATED:20230213T165506Z
LAST-MODIFIED:20230213T165506Z
UID:26949-1677484800-1677488400@scienceinseattle.com
SUMMARY:Global Oncology Lecture Series
DESCRIPTION:Kingsley I. Ndoh\, MD\, MPH \nClinical Assistant Professor\, UW Department of Global Health; Affiliate Member\, Fred Hutch Cancer Center; Founder & Chief Strategist\, Hurone AI \nSeminar Title: “Patient-Reported Outcomes: Leveraging medical technology to address the cancer care gap in underrepresented populations” \nJoin us on Zoom \nPlease register in advance for this meeting! \nAfter registering\, you will receive a confirmation email containing information about joining the meeting.
URL:https://scienceinseattle.com/event/global-oncology-lecture-series-10-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230228T090000
DTEND;TZID=America/Vancouver:20230228T170000
DTSTAMP:20260405T163143
CREATED:20230215T165931Z
LAST-MODIFIED:20230215T165931Z
UID:26955-1677574800-1677603600@scienceinseattle.com
SUMMARY:Expanding Single Cell Capabilities with Immune Profiling and Targeted Gene Capture
DESCRIPTION:Evercode TCR and Gene Capture supports the single cell RNA sequencing community with expanded applications and scalability. Join us for an informative webinar\, in which you will learn about Evercode TCR for immune profiling and Gene Capture for even greater scalability. You will also learn more about Parse’s foundational technology platform\, which enables single cell RNA sequencing with no microfluidics instrument required. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat You’ll Learn About\n\nEvercode TCR for measuring whole transcriptomes and paired TCR sequences – 1 million cells in 1 experiment.\nGene Capture for high resolution data – 10 times less sequencing required. Expanding Single Cell Capabilities\nParse’s foundational Evercode technology – there’s no instrument required.\n\nSpeakers\n\n\n\nCharlie Roco\, PhD\nParse Biosciences\nChief Technology Officer\n\n\n\n\n\n\nAnastasia Potts\, PhD\nParse Biosciences\nSenior Product Manager
URL:https://scienceinseattle.com/event/expanding-single-cell-capabilities-with-immune-profiling-and-targeted-gene-capture-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230228T090000
DTEND;TZID=America/Vancouver:20230228T170000
DTSTAMP:20260405T163143
CREATED:20230215T165931Z
LAST-MODIFIED:20230215T165931Z
UID:21559-1677574800-1677603600@scienceinseattle.com
SUMMARY:Expanding Single Cell Capabilities with Immune Profiling and Targeted Gene Capture
DESCRIPTION:Evercode TCR and Gene Capture supports the single cell RNA sequencing community with expanded applications and scalability. Join us for an informative webinar\, in which you will learn about Evercode TCR for immune profiling and Gene Capture for even greater scalability. You will also learn more about Parse’s foundational technology platform\, which enables single cell RNA sequencing with no microfluidics instrument required. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat You’ll Learn About\n\nEvercode TCR for measuring whole transcriptomes and paired TCR sequences – 1 million cells in 1 experiment.\nGene Capture for high resolution data – 10 times less sequencing required. Expanding Single Cell Capabilities\nParse’s foundational Evercode technology – there’s no instrument required.\n\nSpeakers\n\n\n\nCharlie Roco\, PhD\nParse Biosciences\nChief Technology Officer\n\n\n\n\n\n\nAnastasia Potts\, PhD\nParse Biosciences\nSenior Product Manager
URL:https://scienceinseattle.com/event/expanding-single-cell-capabilities-with-immune-profiling-and-targeted-gene-capture/
LOCATION:Online
END:VEVENT
END:VCALENDAR